PRESERVE-1 is a clinical study for women who develop preeclampsia early in pregnancy, between weeks 23-30.
Like all clinical studies, PRESERVE-1 will determine if a potential treatment is safe and effective in treating preeclampsia.
Should you take part?
Over 25 hospitals in the US are participating in the PRESERVE-1 study.
FIND A TRIAL SITE